Stay updated on Long-term OPA-15406 Ointment Clinical Trial
Sign up to get notified when there's something new on the Long-term OPA-15406 Ointment Clinical Trial page.

Latest updates to the Long-term OPA-15406 Ointment Clinical Trial page
- Check6 days agoChange DetectedThe record describes a completed Phase 3 study of OPA-15406 ointment for adults and children with atopic dermatitis, including its eligibility criteria and safety and efficacy measures. It also provides study publications, documents, and information about sharing participant-level data.SummaryDifference43%

- Check13 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH website updates and says that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe 403 error page’s footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study content and navigation with an access-denied message.SummaryDifference17%

Stay in the know with updates to Long-term OPA-15406 Ointment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term OPA-15406 Ointment Clinical Trial page.